Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(3s)-3-amino-1-(cyclopropylamino)heptane-2,2-diol
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol is a synthetic small molecule with the chemical formula C10H22N2O2 and a molecular weight of approximately 202.29 g/mol. It belongs to the class of dialkylamines and features a cyclopropylamino group attached to a heptanediol backbone. The compound has been cataloged in several chemical databases and is considered experimental; there are no approved medical indications or known clinical uses as of now. No mechanism of action or biological target has been established in public sources[1][2][3][4][5].
- Other names
- (3S)-3-amino-1-(cyclopropylamino)heptane-2,2-diol2,2-heptanediol, 3-amino-1-(cyclopropylamino)-, (3S)
Beyond the preview
Go deeper on (3s)-3-amino-1-(cyclopropylamino)heptane-2,2-diol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (3s)-3-amino-1-(cyclopropylamino)heptane-2,2-diol.